Investor Presentaiton
International formulations: two-fold focus
Focusing on developed generic
markets (~32% of global sales)
✓ US - Zydus Pharmaceuticals USA Inc.
✓ Europe
•
France Zydus France SAS
•
Spain Laboratorios Combix
-
Japan - Zydus Pharmaceuticals Japan Co. Ltd.
Formulations Exports (Rs. Mio.)
3,770
6,465
9,676
14,018
19,215
FY 06-07
FY 07-08
FY 08-09
FY 09-10
FY 10-11
Driving growth in emerging markets
(~11% of global sales)
Brazil -
•
Branded Quimica e Pharmaceutica Nikkho
Do Brazil Ltda.
Generics - Zydus Healthcare Brazil Ltda.
Mexico - Zydus Pharmaceuticals México S.A.
Emerging Markets
•
Asia Pacific- Sri Lanka, Myanmar, Taiwan,
Philippines
South Africa - Simayla Pharma. Pty. Ltd.
Africa, Mid East - Sudan, Uganda, Algeria
Product Portfolio
Robust pipeline of new products across
markets
✓ Initiatives to add specialty and niche
dosage forms in the portfolioView entire presentation